4//SEC Filing
Marquez Michael 4
Accession 0001493152-20-012961
CIK 0001299139other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:15 PM ET
Size
5.3 KB
Accession
0001493152-20-012961
Insider Transaction Report
Form 4
TearLab CorpTEAR
Marquez Michael
Chief Financial Officer
Transactions
- Disposition from Tender
Common Stock
2020-07-09$0.06/sh−500$29→ 0 total
Footnotes (1)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated May 11, 2020 (the "Merger Agreement"), among Accelmed Partners II LP, a Cayman Islands exempted limited partnership ("Buyer"), the Issuer and Accelmed Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer, each issued and outstanding share of Issuer common stock and preferred stock (other than Cancelled Shares (as defined in the Merger Agreement)) was cancelled and automatically converted into the right to receive an amount equal to $0.0586 per share in cash, without interest and less any required withholding taxes, effective at the time of the Merger (as defined in the Merger Agreement).
Documents
Issuer
TearLab Corp
CIK 0001299139
Entity typeother
Related Parties
1- filerCIK 0001736244
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:15 PM ET
- Size
- 5.3 KB